OSUR
OraSure Technologies, Inc.
Medical - Instruments & Supplies
Market Cap$217M
5Y Perf.-79.4%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
OSUR vs DBVT
Revenue, margins, valuation, and 5-year total return — side by side.
DBVT
DBV Technologies S.A.
Biotechnology
Market Cap$1669.52T
5Y Perf.-56.7%
OSUR vs DBVT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | OSUR | DBVT |
|---|---|---|
| Industry | Medical - Instruments & Supplies | Biotechnology |
| Market Cap | $217M | $1669.52T |
| Revenue (TTM) | $115K | $0.00 |
| Net Income (TTM) | $-49M | $-168M |
| Gross Margin | 41.9% | — |
| Operating Margin | -59.2% | — |
| Total Debt | $0.00 | $22M |
| Cash & Equiv. | $199K | $194M |
OSUR vs DBVT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
OSUR
DBVT
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| OraSure Technologie… (OSUR) | 100 | 20.6 | -79.4% |
| DBV Technologies S.… (DBVT) | 100 | 43.3 | -56.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: OSUR vs DBVT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: DBVT leads in 4 of 6 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. OraSure Technologies, Inc. is the stronger pick specifically for growth and revenue expansion. As sector peers, any of these can serve as alternatives in the same allocation.
OSUR
OraSure Technologies, Inc.
The Income Pick
OSUR is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 2 yrs, beta 1.45
- Rev growth -99.9%, EPS growth -261.5%, 3Y rev CAGR -93.3%
- -53.9% 10Y total return vs DBVT's -87.1%
Best for: income & stability and growth exposure
DBVT
DBV Technologies S.A.
The Defensive Pick
DBVT carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and defensive.
- Lower volatility, beta 1.26, Low D/E 12.8%, current ratio 3.67x
- Beta 1.26, current ratio 3.67x
- 0.3% margin vs OSUR's -430.0%
Best for: sleep-well-at-night and defensive
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | OSUR | -99.9% revenue growth vs DBVT's -100.0% |
| Quality / Margins | DBVT | 0.3% margin vs OSUR's -430.0% |
| Stability / Safety | DBVT | Beta 1.26 vs OSUR's 1.45 |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | DBVT | +110.7% vs OSUR's +5.3% |
| Efficiency (ROA) | DBVT | -89.0% ROA vs OSUR's -122.7% |
OSUR vs DBVT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2024
Segment breakdown not available.
OSUR vs DBVT — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLOSURLAGGINGDBVT
DBVTDBV Technologies S.A.
1leads
OSUROraSure Technologies,…
2leads
6 Total Categories
CATEGORYLEADERvs DBVTMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
DBVT1/1
Valuation MetricsMultiples, price ratios, and targets
OSUR1/1
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
Tied
—
Total Returns1Y, 3Y, 5Y total returns with dividends
Tied
—
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
OSUR1/1
Income & Cash Flow (Last 12 Months)
DBVT leads this category, winning 1 of 1 comparable metric.
Income & Cash Flow (Last 12 Months)
OSUR and DBVT operate at a comparable scale, with $115,021 and $0 in trailing revenue.
| Metric | OSUROraSure Technolog… | DBVTDBV Technologies … |
|---|---|---|
| RevenueTrailing 12 months | $115,021 | $0 |
| EBITDAEarnings before interest/tax | -$44M | -$112M |
| Net IncomeAfter-tax profit | -$49M | -$168M |
| Free Cash FlowCash after capex | -$93M | -$151M |
| Gross MarginGross profit ÷ Revenue | +41.9% | — |
| Operating MarginEBIT ÷ Revenue | -59.2% | — |
| Net MarginNet income ÷ Revenue | -430.0% | — |
| FCF MarginFCF ÷ Revenue | -811.8% | — |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.4% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -92.9% | +91.5% |
DBVT leads this category, winning 1 of 1 comparable metric.
Valuation Metrics
OSUR leads this category, winning 1 of 1 comparable metric.
Valuation Metrics
| Metric | OSUROraSure Technolog… | DBVTDBV Technologies … |
|---|---|---|
| Market CapShares × price | $217M | $1669.52T |
| Enterprise ValueMkt cap + debt − cash | $217M | $1669.52T |
| Trailing P/EPrice ÷ TTM EPS | -3.19x | -0.74x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 1884.83x | — |
| Price / BookPrice ÷ Book value/share | — | 0.64x |
| Price / FCFMarket cap ÷ FCF | — | — |
OSUR leads this category, winning 1 of 1 comparable metric.
Profitability & Efficiency
Evenly matched — OSUR and DBVT each lead in 2 of 4 comparable metrics.
Profitability & Efficiency
| Metric | OSUROraSure Technolog… | DBVTDBV Technologies … |
|---|---|---|
| ROE (TTM)Return on equity | — | -130.2% |
| ROA (TTM)Return on assets | -122.7% | -89.0% |
| ROICReturn on invested capital | — | — |
| ROCEReturn on capital employed | -0.0% | -145.7% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 4 |
| Debt / EquityFinancial leverage | — | 0.13x |
| Net DebtTotal debt minus cash | -$199,278 | -$172M |
| Cash & Equiv.Liquid assets | $199,278 | $194M |
| Total DebtShort + long-term debt | $0 | $22M |
| Interest CoverageEBIT ÷ Interest expense | — | -189.82x |
Evenly matched — OSUR and DBVT each lead in 2 of 4 comparable metrics.
Total Returns (Dividends Reinvested)
Evenly matched — OSUR and DBVT each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in OSUR five years ago would be worth $3,326 today (with dividends reinvested), compared to $3,041 for DBVT. Over the past 12 months, DBVT leads with a +110.7% total return vs OSUR's +5.3%. The 3-year compound annual growth rate (CAGR) favors DBVT at 5.7% vs OSUR's -24.6% — a key indicator of consistent wealth creation.
| Metric | OSUROraSure Technolog… | DBVTDBV Technologies … |
|---|---|---|
| YTD ReturnYear-to-date | +26.1% | +2.3% |
| 1-Year ReturnPast 12 months | +5.3% | +110.7% |
| 3-Year ReturnCumulative with dividends | -57.1% | +18.1% |
| 5-Year ReturnCumulative with dividends | -66.7% | -69.6% |
| 10-Year ReturnCumulative with dividends | -53.9% | -87.1% |
| CAGR (3Y)Annualised 3-year return | -24.6% | +5.7% |
Evenly matched — OSUR and DBVT each lead in 3 of 6 comparable metrics.
Risk & Volatility
Evenly matched — OSUR and DBVT each lead in 1 of 2 comparable metrics.
Risk & Volatility
DBVT is the less volatile stock with a 1.26 beta — it tends to amplify market swings less than OSUR's 1.45 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. OSUR currently trades 78.5% from its 52-week high vs DBVT's 74.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | OSUROraSure Technolog… | DBVTDBV Technologies … |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.45x | 1.26x |
| 52-Week HighHighest price in past year | $3.82 | $26.18 |
| 52-Week LowLowest price in past year | $2.08 | $7.53 |
| % of 52W HighCurrent price vs 52-week peak | +78.5% | +74.4% |
| RSI (14)Momentum oscillator 0–100 | 43.1 | 43.7 |
| Avg Volume (50D)Average daily shares traded | 451K | 249K |
Evenly matched — OSUR and DBVT each lead in 1 of 2 comparable metrics.
Analyst Outlook
OSUR leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates OSUR as "Hold" and DBVT as "Buy". Consensus price targets imply 137.7% upside for DBVT (target: $46) vs 33.3% for OSUR (target: $4).
| Metric | OSUROraSure Technolog… | DBVTDBV Technologies … |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $4.00 | $46.33 |
| # AnalystsCovering analysts | 13 | 15 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 2 | 0 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.0% | 0.0% |
OSUR leads this category, winning 1 of 1 comparable metric.
Key Takeaway
OSUR leads in 2 of 6 categories (Valuation Metrics, Analyst Outlook). DBVT leads in 1 (Income & Cash Flow). 3 tied.
Best OverallOraSure Technologies, Inc. (OSUR)Leads 2 of 6 categories
Loading custom metrics...
OSUR vs DBVT: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is OSUR or DBVT a better buy right now?
Analysts rate DBV Technologies S.
A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — OSUR or DBVT?
Over the past 5 years, OraSure Technologies, Inc.
(OSUR) delivered a total return of -66. 7%, compared to -69. 6% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: OSUR returned -53. 9% versus DBVT's -87. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — OSUR or DBVT?
By beta (market sensitivity over 5 years), DBV Technologies S.
A. (DBVT) is the lower-risk stock at 1. 26β versus OraSure Technologies, Inc. 's 1. 45β — meaning OSUR is approximately 15% more volatile than DBVT relative to the S&P 500.
04Which is growing faster — OSUR or DBVT?
On earnings-per-share growth, the picture is similar: OraSure Technologies, Inc.
grew EPS -261. 5% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — OSUR or DBVT?
DBV Technologies S.
A. (DBVT) is the more profitable company, earning 0. 0% net margin versus -59. 8% for OraSure Technologies, Inc. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DBVT leads at 0. 0% versus -59. 2% for OSUR. At the gross margin level — before operating expenses — OSUR leads at 41. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — OSUR or DBVT?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is OSUR or DBVT better for a retirement portfolio?
For long-horizon retirement investors, DBV Technologies S.
A. (DBVT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 26)). Both have compounded well over 10 years (DBVT: -87. 1%, OSUR: -53. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between OSUR and DBVT?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.